SeaStar terminates $100M equity purchase agreement with Tumim Stone Capital

SeaStar Medical Holding Corp

Mutual consent termination of Common Stock Purchase Agreement effective February 15, 2024.
Agreement originally disclosed in August 2022, amended November 2022, provided up to $100M equity line.
Eliminates a committed equity facility that was a potential source of funding.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

SeaStar Medical Holding Corp terminated Common Stock Purchase Agreement with Tumim Stone Capital LLC valued at up to $100 million (effective 2024-02-15).

Action: termination
Agreement: equity purchase
Counterparty: Tumim Stone Capital LLC
Value: up to $100 million
Effective: 2024-02-15

Exact text from the filing

On February 15, 2024, the Parties to the Purchase Agreement agreed by mutual consent and pursuant to its terms to terminate the Purchase Agreement, effective immediately.

View on SEC.gov

Browse all material agreements →

SeaStar Medical Holding Corp filing history →

Source: SEC EDGAR

accession 0000950170-24-016160

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.